Salidroside postconditioning attenuates ferroptosis-mediated lung ischemia-reperfusion injury by activating the Nrf2/SLC7A11 signaling axis
- 20 January 2023
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 115, 109731
Abstract
No abstract availableKeywords
Funding Information
- Wuhan University (PDJH202205)
- National Natural Science Foundation of China (82002033)
- Natural Science Foundation of Hubei Province (2020CFB214)
This publication has 28 references indexed in Scilit:
- Ferroptosis: past, present and futureCell Death & Disease, 2020
- Salidroside ameliorates endothelial inflammation and oxidative stress by regulating the AMPK/NF-κB/NLRP3 signaling pathway in AGEs-induced HUVECsEuropean Journal of Pharmacology, 2020
- Salidroside enhances the anti-cancerous effect of imatinib on human acute monocytic leukemia via the induction of autophagy-related apoptosis through AMPK activationRSC Advances, 2019
- Tubular GM-CSF Promotes Late MCP-1/CCR2-Mediated Fibrosis and Inflammation after Ischemia/Reperfusion InjuryJournal of the American Society of Nephrology, 2019
- The post-cardiac arrest syndrome: A case for lung–brain coupling and opportunities for neuroprotectionJournal of Cerebral Blood Flow & Metabolism, 2019
- Salidroside improves brain ischemic injury by activating PI3K/Akt pathway and reduces complications induced by delayed tPA treatmentEuropean Journal of Pharmacology, 2018
- Primary Graft Dysfunction (PGD) Following Lung TransplantationSeminars in Respiratory and Critical Care Medicine, 2018
- Salidroside protects rat liver against ischemia/reperfusion injury by regulating the GSK-3β/Nrf2-dependent antioxidant response and mitochondrial permeability transitionEuropean Journal of Pharmacology, 2017
- Salidroside Attenuates LPS-Induced Acute Lung Injury in RatsInflammation, 2017
- Mechanisms of lung ischemia-reperfusion injuryCurrent Opinion in Organ Transplantation, 2016